Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Wiseman

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Science|April 28, 2026
An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter StudyYu-Hung Wang, Carmelo Gurnari, Valeria Visconte, et al.
Cell Reports|March 29, 2018
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid LeukemiaAlba Maiques-Diaz, Gary J Spencer, James T Lynch, et al.
Blood|April 5, 2013
A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)Daniel H Wiseman, Alison May, Stephen Jolles, et al.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Cell Stem Cell|June 2, 2023
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophilsHector Huerga Encabo, Iker Valle Aramburu, Manuel Garcia-Albornoz, et al.
Leukemia|February 21, 2020
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implicationsShalini Singh, Doaa Ahmed, Hamid Dolatshad, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
British Journal of Haematology|May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemiaAna M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Science|April 28, 2026
An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter StudyYu-Hung Wang, Carmelo Gurnari, Valeria Visconte, et al.
Cell Reports|March 29, 2018
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid LeukemiaAlba Maiques-Diaz, Gary J Spencer, James T Lynch, et al.
Blood|April 5, 2013
A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)Daniel H Wiseman, Alison May, Stephen Jolles, et al.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Cell Stem Cell|June 2, 2023
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophilsHector Huerga Encabo, Iker Valle Aramburu, Manuel Garcia-Albornoz, et al.
Leukemia|February 21, 2020
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implicationsShalini Singh, Doaa Ahmed, Hamid Dolatshad, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
British Journal of Haematology|May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemiaAna M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Pageof 6